Elevance Health Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $199.13B | $177.01B | $171.34B | $156.05B | $137.10B | $121.10B | $104.01B |
| Premiums | — | — | — | $142.88B | $132.97B | $117.14B | $104.27B | $92.02B |
| Product Revenues | — | — | — | $26.46B | $21.44B | $18.49B | $15.32B | $10.41B |
| Administrative Fees and Other | — | — | — | $2.00B | $1.65B | $1.48B | $1.51B | $1.59B |
| Cost of Revenue | — | $21.18B | $19.75B | $17.29B | $13.04B | $10.90B | $8.95B | $1.99B |
| Gross Profit | — | $177.95B | $157.26B | $154.05B | $143.02B | $126.21B | $112.15B | $102.02B |
| Gross Margin | — | 89.4% | 88.8% | 89.9% | 91.6% | 92.1% | 92.6% | 98.1% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $20.98B | $20.03B | $20.09B | $17.70B | $15.92B | $17.45B | $13.36B |
| Operating Income | — | $7.20B | $7.86B | $8.50B | $8.28B | $7.56B | $6.36B | $6.00B |
| Operating Margin | — | 3.6% | 4.4% | 5.0% | 5.3% | 5.5% | 5.3% | 5.8% |
| Interest Expense | — | — | — | $1.03B | $851.0M | $798.0M | $784.0M | $746.0M |
| Pretax Income | — | $6.71B | $7.90B | $7.72B | $7.60B | $8.00B | $6.24B | $5.99B |
| Income Tax Expense | — | $1.05B | $1.93B | $1.72B | $1.71B | $1.85B | $1.67B | $1.18B |
| Net Income | — | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B | $4.81B |
| Net Margin | — | 2.8% | 3.4% | 3.5% | 3.8% | 4.5% | 3.8% | 4.6% |
| EPS (Basic) | — | $25.28 | $25.81 | $25.38 | $24.56 | $25.26 | $18.23 | $18.81 |
| EPS (Diluted) | — | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 | $17.98 | $18.47 |
| Shares Outstanding (Basic) | 220.7M | 224.0M | 231.7M | 235.9M | 240.0M | 243.8M | 250.8M | 255.5M |
| Shares Outstanding (Diluted) | 220.7M | 224.6M | 232.9M | 237.4M | 242.8M | 246.8M | 254.3M | 260.3M |
| Dividends Per Share | — | — | — | $5.92 | $5.12 | $4.52 | $3.80 | $3.20 |